Chad Michael Walesky

Chad Michael Walesky

Auto-generated profile, based on publicly available information

Chad Michael Walesky

Genetics Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 02115, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
CWChad M. Walesky
Chad M. Walesky
KKKellie E. Kolb
Kellie E. Kolb
CWCarolyn L. Winston
Carolyn L. Winston
JHJake Henderson
Jake Henderson
BKBenjamin Kruft
Benjamin Kruft
WGWolfram Goessling
Wolfram Goessling
The liver plays a central role in metabolism, protein synthesis and detoxification. It possesses unique regenerative capacity upon injury. While many factors regulating cellular proliferation during liver repair have been identified, the mechanisms by which the injured liver maintains vital functions prior to tissue recovery are unknown. Here, we identify a new phase of functional compensation following acute liver injury that occurs prior to cellular proliferation. By coupling single-cell RNA-seq with in situ transcriptional analyses in two independent murine liver injury models, we discover adaptive reprogramming to ensure expression of both injury response and core liver function genes dependent on macrophage-derived WNT/β-catenin signaling. Interestingly, transcriptional compensation is most prominent in non-proliferating cells, clearly delineating two temporally distinct phases of liver recovery. Overall, our work describes a mechanism by which the liver maintains essential physiological functions prior to cellular reconstitution and characterizes macrophage-derived WNT signals required for this compensation.

1 April 2012 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
CWChad Michael Walesky
Chad Michael Walesky
SGSumedha Gunewardena
Sumedha Gunewardena
GEGenea Edwards
Genea Edwards
Udayan ApteUdayan Apte
Udayan Apte
HNF4α, the master regulator of hepatocyte differentiation, has been shown to inhibit hepatocyte proliferation via yet to be identified mechanisms. We investigated the mechanisms of HNF4α‐induced inhibition of hepatocyte proliferation using two novel HNF4α knockdown mouse models. Hepatocyte specific deletion of HNF4α resulted in increased hepatocyte proliferation. Comparative global gene expression analysis revealed a set of genes commonly regulated in both HNF4α deletion models. The majority of the down‐regulated genes are known HNF4α target genes involved in hepatic differentiation. Interestingly, many up‐regulated genes were associated with cell proliferation and cancer. HNF4α knockdown mice treated with the known hepatic carcinogen diethylnitrosamine developed a 7‐fold increase in number of tumors, as compared to controls. Furthermore, in vitro over expression of HNF4α in mouse HCC cells resulted in a decrease in cell proliferation along with a decrease in promitogenic gene expression. Taken together these data indicate that HNF4α inhibits hepatocyte proliferation by repression of specific pro‐mitogenic genes.